The global cholera vaccine market size in 2017 is $ 65 million and is projected to reach $207 million by 2027, growing at a CAGR of 15% from 2021 to 2027.
Cholera is one of the most prevalent infectious diseases caused by the bacteria Vibrio cholera. It can lead to death and causes severe diarrhea that requires immediate medical attention. According to the World Health Organization (WHO), nearly 21,000 to 1,43,000 people died of cholera worldwide in 2019. In addition, nearly 1.3 to 4 million cases of cholera are registered worldwide each year. Therefore, as the incidence of cholera increases, there will be significant demand for cholera vaccines over the expected period.
(Get 15% Discount on Buying this Report)
A full report of Global Cholera Vaccines Market is available at: https://www.orionmarketreports.com/cholera-vaccines-market/54145/
Market Segments
By Product
- Dukoral
- Shanchol
- Vaxchora
- Euvichol & Euvichol-Plus
- Others
By End-User
- Hospitals & clinics
- Research & Academic Laboratories
- Others
Key Players
- Valneva SE
- PaxVax, Inc.
- Astellas Pharma, Inc.
- Merck & Co., Inc.
- GlaxoSmithKline plc (GSK)
- Pfizer, Inc.
- Takeda Pharmaceutical Co., Ltd.
- Emergent BioSolutions, Inc.
- AstraZeneca
Scope of the Report
The research study analyzes the global Cholera Vaccines industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Cholera Vaccines Market Report
1. What was the Cholera Vaccines Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
2. What will be the CAGR of the Cholera Vaccines Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Cholera Vaccines Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Cholera Vaccines market.
- The market share of the global Cholera Vaccines market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Cholera Vaccines market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Cholera Vaccines market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
